HCA Healthcare, Inc. operates as a healthcare services provider, primarily focused on owning and operating hospitals and related healthcare facilities. Its core services include inpatient and outpatient care, emergency services, and surgical services. The company generates revenue mainly from patient services, including admissions and surgeries, as well as ancillary services such as laboratory and imaging services. HCA operates in various segments, including acute care hospitals and outpatient services, contributing significantly to its overall revenue.
The investment profile of HCA is more aligned with value investors, given its relatively stable revenue streams and modest dividend yield. The stock may appeal to those seeking a balance between income and capital appreciation, although recent performance indicates potential challenges. Investors should consider the company's risk factors and market conditions when evaluating its suitability for their portfolios.
| Date | Before | After | Reason |
|---|---|---|---|
| 2026-07-09 | Hold | Sell | Weak fundamentals and negative momentum raise concerns. |
| 2026-06-27 | Sell | Hold | Weak fundamentals and negative momentum raise concerns. |
| 2026-06-09 | Hold | Sell | Weak fundamentals and negative momentum raise significant concerns. |
| 2026-05-30 | Sell | Hold | Weak fundamentals and negative momentum indicate high risk. |
| 2026-05-16 | Hold | Sell | Weak fundamentals and negative momentum signal high risk. |
| 2026-05-08 | — | Hold | Weak momentum and fundamentals suggest caution. |
| 2026-05-08 | Hold | Hold | Компания HCA демонстрирует снижение выручки и негативные тренды на краткосрочном горизонте, что вызывает опасения по поводу её будущих финансовых показателей. Однако, стабильный EPS и дивидендная доходность могут поддерж |
| 2026-04-25 | Buy | Hold | Компания HCA демонстрирует значительное снижение цен на акции за последние месяцы, что указывает на высокие риски. При этом низкий дивидендный доход и нестабильный рост выручки могут негативно сказаться на будущих перспе |
| 2026-04-01 | Hold | Buy | Компания HCA демонстрирует стабильный рост выручки и положительные финансовые показатели, однако недавнее снижение цен акций на 12.65% за 20 дней может указывать на краткосрочные риски. |
| 2026-03-23 | Buy | Hold | Компания HCA демонстрирует стабильный рост выручки и положительный тренд на длительном горизонте, однако недавнее снижение цен акций и высокая волатильность могут указывать на краткосрочные риски. |
| Date | Analyst | Action | Target | Price Then |
|---|---|---|---|---|
| 2026-07-20 | Wells Fargo | Target Lowered | 428 → 369 | 371.18 |
| 2026-07-16 | Barclays | Target Lowered | 427 → 402 | 378.85 |
| 2026-07-15 | RBC Capital | Target Lowered | 534 → 435 | 363.6 |
| 2026-07-14 | Jefferies | Target Lowered | 525 → 450 | 363.6 |
| 2026-07-13 | Wells Fargo | Target Lowered | 436 → 428 | 406.59 |
| 2026-07-08 | Barclays | Rating Downgraded | — → 427 | 423.11 |
| 2026-07-07 | Raymond James | Target Lowered | — → 528 | 424.79999 |
| 2026-07-07 | Cantor Fitzgerald | Target Lowered | 588 → 525 | 417.07 |
| 2026-06-04 | Truist Financial | Target Lowered | — → 413 | 367.69 |
| 2026-06-04 | Bernstein | Target Lowered | 503 → 413 | 363.23 |
| 2026-04-27 | Stephens | Target Lowered | 560 → 530 | 444.76 |
| 2026-04-27 | Truist Financial | Target Lowered | 546 → 535 | 432.46 |
| 2026-04-27 | Oppenheimer | Target Lowered | 540 → 520 | 432.46 |
| 2026-04-27 | RBC Capital | Target Lowered | 593 → 534 | 432.46 |
| 2026-04-27 | Wells Fargo | Target Lowered | 481 → 436 | 432.46 |
| 2026-04-27 | KeyBanc | Target Lowered | 550 → 510 | 432.46 |
| 2026-04-27 | Barclays | Target Lowered | 551 → 496 | 432.46 |
| 2026-04-24 | Jefferies | Target Lowered | 590 → 525 | 432.46 |
| 2026-02-23 | UBS | Target Raised | 598 → 635 | 532.3 |
| 2026-02-09 | Bernstein | Target Raised | 503 → 541 | 501.69 |
